Showing 281 - 300 results of 1,890 for search '"Type 2 diabetes"', query time: 0.10s Refine Results
  1. 281

    Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients by Agnieszka Żyłka, Paulina Dumnicka, Beata Kuśnierz-Cabala, Agnieszka Gala-Błądzińska, Piotr Ceranowicz, Jakub Kucharz, Anna Ząbek-Adamska, Barbara Maziarz, Ryszard Drożdż, Marek Kuźniewski

    Published 2018-01-01
    “…Diabetic kidney disease develops in half of genetically predisposed patients with type 2 diabetes (T2DM). Early diagnosis of kidney damage and nephroprotective treatment are the ways of preventing the disease progression. …”
    Get full text
    Article
  2. 282

    Investigating Factors Associated with Depressive Symptoms of Chronic Kidney Diseases in China with Type 2 Diabetes by Xu Wang, Biyu Shen, Xun Zhuang, Xueqin Wang, Weiqun Weng

    Published 2017-01-01
    “…To assess the depressive symptoms status of chronic kidney diseases in Nantong, China, with type 2 diabetes and to identify factors associated with depressive symptoms. …”
    Get full text
    Article
  3. 283
  4. 284

    Burden of micronutrient deficiency among patients with type 2 diabetes: systematic review and meta-analysis by Sanjay Kalra, Shiv Dutt Gupta, Daya Krishan Mangal, Diksha Gautam, Anuj Kumar Pandey, Nida Shaikh, Himanshu Tolani, Yeshwanth Sonnathi, Kamlesh Chand Sharma, Jagdish Prasad, Rajeev Tewari, Fahmina Anwar

    “…These deficiencies can impact glucose metabolism and insulin signalling pathways, potentially leading to the beginning and advancement of type 2 diabetes (T2D). This study is a comprehensive assessment of the burden of multiple micronutrient deficiencies among T2D patients. …”
    Get full text
    Article
  5. 285

    Relationship between Altered Platelet Morphological Parameters and Retinopathy in Patients with Type 2 Diabetes Mellitus by Tolga Yilmaz, Ahu Yilmaz

    Published 2016-01-01
    “…This prospective study enrolled 85 healthy controls (HCs) (group 1) and 262 patients with Type 2 diabetes mellitus (T2DM). Patients were subclassified into three groups according to ocular findings: no DR (group 2; n=88); nonproliferative DR (group 3; n=88), and proliferative DR (group 4; n=86). …”
    Get full text
    Article
  6. 286

    Growth Hormone Therapy for Small for Gestational Age Short Stature Develops Type 2 Diabetes by Naohiro Nomura, Yuko Tanabe, Miki Minami, Junji Takaya, Kazunari Kaneko

    Published 2023-01-01
    “…The patient’s father and paternal grandfather were diagnosed with type 2 diabetes mellitus. At 3 years of age, the patient presented with short stature; height and weight were 85 cm (−2.5 SD) and 13 kg (−0.19 SD), respectively. …”
    Get full text
    Article
  7. 287

    The Relation between Periodontopathogenic Bacterial Levels and Resistin in the Saliva of Obese Type 2 Diabetic Patients by Natheer Al-Rawi, Farah Al-Marzooq

    Published 2017-01-01
    “…In this study, high salivary resistin was associated with obesity, which is a major predisposing factor for type 2 diabetes and also a risk factor for oral diseases. …”
    Get full text
    Article
  8. 288

    Molecular Structure, Membrane Interactions, and Toxicity of the Islet Amyloid Polypeptide in Type 2 Diabetes Mellitus by Lucie Caillon, Anais R. F. Hoffmann, Alexandra Botz, Lucie Khemtemourian

    Published 2016-01-01
    “…Human islet amyloid polypeptide (hIAPP) is the major component of the amyloid deposits found in the pancreatic islets of patients with type 2 diabetes mellitus (T2DM). Mature hIAPP, a 37-aa peptide, is natively unfolded in its monomeric state but forms islet amyloid in T2DM. …”
    Get full text
    Article
  9. 289
  10. 290

    Reshaping lipid metabolism with long-term alternate day feeding in type 2 diabetes mice by Eleni Beli, Yuanqing Yan, Leni Moldovan, Todd A. Lydic, Preethi Krishman, Sarah A. Tersey, Yaqian Duan, Tatiana E. Salazar, James M. Dominguez, Dung V. Nguyen, Abigail Cox, Sergio Li Calzi, Craig Beam, Raghavendra G. Mirmira, Carmella Evans-Molina, Julia V. Busik, Maria B. Grant

    Published 2025-02-01
    “…The chronicity of type 2 diabetes (T2D) requires that interventions must be undertaken for extended periods of time, typically the entire lifetime of the individual. …”
    Get full text
    Article
  11. 291

    Inulin Reduces Kidney Damage in Type 2 Diabetic Mice by Decreasing Inflammation and Serum Metabolomics by Jiayuan He, Xiang Li, Man Yan, Xinsheng Chen, Chang Sun, Jiajun Tan, Yinsheng Song, Hong Xu, Liang Wu, Zhengnan Yang

    Published 2024-01-01
    “…This study is aimed at assessing the impact of soluble dietary fiber inulin on the treatment of diabetes-related chronic inflammation and kidney injury in mice with type 2 diabetes (T2DM). The T2DM model was created by feeding the Institute of Cancer Research (ICR) mice a high-fat diet and intraperitoneally injecting them with streptozotocin (50 mg/kg for 5 consecutive days). …”
    Get full text
    Article
  12. 292

    Lifestyle Interventions to Prevent Type 2 Diabetes: A Systematic Review of Economic Evaluation Studies by Koffi Alouki, Hélène Delisle, Clara Bermúdez-Tamayo, Mira Johri

    Published 2016-01-01
    “…To summarize key findings of economic evaluations of lifestyle interventions for the primary prevention of type 2 diabetes (T2D) in high-risk subjects. Methods. …”
    Get full text
    Article
  13. 293
  14. 294
  15. 295
  16. 296

    Age- and Gender-Related Differences in LDL-Cholesterol Management in Outpatients with Type 2 Diabetes Mellitus by Giuseppina Russo, Basilio Pintaudi, Carlo Giorda, Giuseppe Lucisano, Antonio Nicolucci, Maria Rosaria Cristofaro, Concetta Suraci, Maria Franca Mulas, Angela Napoli, Maria Chiara Rossi, Valeria Manicardi

    Published 2015-01-01
    “…Dyslipidemia contribute to the excess of coronary heart disease (CHD) risk observed in women with type 2 diabetes (T2DM). Low density lipoprotein-cholesterol (LDL-C) is the major target for CHD prevention, and T2DM women seem to reach LDL-C targets less frequently than men. …”
    Get full text
    Article
  17. 297
  18. 298

    Sociodemographic and Pathological Characterization of Patients with Type 2 Diabetes Mellitus Treated in Peru Medical Center by José Ander Asenjo Alarcón

    Published 2021-06-01
    “…<strong>Background:</strong> type 2 diabetes mellitus is a very frequent chronic disease. …”
    Get full text
    Article
  19. 299

    Sexual Differences in response to Mid- or Low-Premixed Insulin Analogue in Patients with Type 2 Diabetes by Bing-li Liu, Xiao-mei Liu, Yi-fei Ren, Yi-Xuan Sun, Meng-hui Luo, Lei Ye, Jian-hua Ma, Feng-fei Li

    Published 2020-01-01
    “…To observe whether there are sexual-related differences in response to mid- or low-premixed insulin in type 2 diabetic patients. Methods. This was an analysis of CGM data of a previous study. …”
    Get full text
    Article
  20. 300

    Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China by J. Ma, L. Y. Liu, P. H. Wu, Y. Liao, T. Tao, W. Liu

    Published 2014-01-01
    “…This study was designed to compare the effects of metformin and repaglinide on the fasting plasma glucose (FPG) and glycated haemoglobin (HbA1c) in newly diagnosed type 2 diabetes in China. Methods. A total of 107 newly diagnosed type 2 diabetic patients (46 women and 61 men) participated in the study. …”
    Get full text
    Article